Has FDA effectively slammed the door shut on DMAA?
Will a new, negative Department of Health and Human Services report follow the dietary supplements industry for years?
Recently ramped-up enforcement against synthetic botanicals means FDA needs to readdress synthetic botanicals in the draft guidance even before revising other parts, CRN wrote.
One of the reports, on structure-function claims, reports finding dubious claims on numerous products.
By developing proper SOPs for laboratory qualification, industry can hopefully work to eliminate the problem of "dry labbing" altogether.
CRN's Mister Responds to Senators Durbin and Blumenthal: Compliance Requires Both a “Carrot and a Stick”
The former FDA senior scientist has spent 17 years with CRN.
The director of FDA’s Center for Food Safety and Applied Nutrition will address critical regulatory topics, including NDIs, GMPs, and AERs.
In terms of timeline, CRN said that FDA has not stated when it expects to issue the new draft guidance.
In the midst of the well-publicized legal fight between POM Wonderful (Los Angeles) and the FTC, there appears to be some good news—for the larger dietary supplements industry, at least.
Join the Nutra-Q Suppliers Directory! Be a part of the industry's only qualified database of suppliers.
© 2013 NutritionalOutlook.com